Trump's new tariff move may raise U.S. pharma costs, with analysts warning of risks tied to EU manufacturing and shifting healthcare policies.

In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $484.01, marking a +0.11% move from the previous day. This change outpaced the S&P 500's 4.84% loss on the day. At the same time, ...

Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its target price boosted by Royal Bank of Canada from $408.00 to $420.00 in a research report sent to investors on Tuesday morning,Benzinga ...

BGC Group Inc., a financial firm controlled by the billionaire Lutnick family, bought brokerage OTC Global Holdings for $325 ...

In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $502.55, marking a +0.45% move from the previous day. The stock's change was more than the S&P 500's daily loss of 0.33%. At the ...

In February, the non-profit brokerage group lodged a submission with the NSW Parliament, asking the NSW government to update its legislation. MFAA argued that payroll obligations shouldn't be extended ...

The emails, sent to select carriers, introduce Walmart’s brokerage program and outline the benefits of participation. “We’re connecting with a select group of carriers like yourself to ...

In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated ... mostly powered by a concentrated group of major tech and communication companies, commonly known ...

In the latest development, Google today announced that it would be adding Chirp 3 — its speech-to-text and HD text-to-speech models — to its Vertex AI development platform starting next week.

China’s 12 trillion yuan (US$1.6 trillion) brokerage sector will continue to remain fragmented and competitive, despite the ongoing consolidation mandated by Beijing to create world-class ...

Its Platinum Tier and Diamond Tier have fixed monthly charges of $48 and $128 respectively, but incur lower brokerage commissions and more free trades per month. – DBS Vickers charges a custodian fee ...

Vertex Pharmaceuticals (VRTX) will release its next Annual Report on n/a. Vertex Pharmaceuticals's (VRTX) last annual report was released on n/a. DISCLOSURE: InvestSMART Group Limited employees may ...